PHP
PLSE icon

Parkman Healthcare Partners’s Pulse Biosciences PLSE Stock Holding History

Parkman Healthcare Partners’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.08M Buy
+50,125
New +$925K 0.11% 83

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Parkman Healthcare Partners's PLSE Position: Q1 2026 in Review

Parkman Healthcare Partners opened a new position in Pulse Biosciences (PLSE) in Q1 2026: 50,125 shares worth $1.08M. The stake represents 0.11% of the portfolio and ranks #83 among its holdings.

96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Parkman Healthcare Partners held 50,125 shares of Pulse Biosciences worth $1.08M as of Q1 2026.
  • Pulse Biosciences was a new Parkman Healthcare Partners position in Q1 2026.
  • Pulse Biosciences made up 0.11% of Parkman Healthcare Partners's portfolio in Q1 2026, its #83 holding.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.